• Research & Development

  Promising New Treatment for Portopulmonary Hypertension

  Posted by Pulmonary Hypertension News Moderator on September 20, 2018 at 7:44 am

  The results of a Phase 4 clinical study suggest that Actelion’s Opsumit may be a therapeutic option for patients with portopulmonary hypertension. Read the full story here.

  What do you think about the study and its results?

  replied 7 years, 5 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply